AL-009 shows antitumor efficacy both as monotherapy and in combination with anti-PD-L1 Nov. 22, 2021 No Comments
Replication stress response defects signature predicts ICB response in nonhypermutated cancers Nov. 19, 2021 No Comments
SGN-PDL1V, a PD-L1-directed ADC with activity in multiple tumor xenograft models Nov. 19, 2021 No Comments
Antibody-drug conjugate SGN-B7H4V shows promise in preclinical models of cancer Nov. 19, 2021 No Comments
CoImmune enters research collaboration with Yeda Research and Development on SIN technology Nov. 18, 2021 No Comments
Innate checkpoint inhibitor ASD-141 inhibits tumor growth in colon cancer models Nov. 18, 2021 No Comments
Preclinical results presented on a novel conditionally activated IFN-alpha INDUKINE molecule Nov. 18, 2021 No Comments
RSS